Jin, Jing
Guo, Shan-Shan
Liu, Li-Ting
Wen, Dong-Xiang
Liu, Rong-Ping
Lin, Jie-Yi
Liu, Si-Qi
Sun, Xue-Song
Liang, Yu-Jing
Tang, Lin-Quan
Mai, Hai-Qiang
Chen, Qiu-Yan
Funding for this research was provided by:
National Natural Science Foundation of China (32200651, 82203776, 82203125, 82222050, 82272739, 82272882, 82173287, 82073003, 82003267, 82002852)
Natural Science Foundation of Guangdong Province for Distinguished Young Scholar (2018B030306001)
Pearl River S&T Nova Program of Guangzhou (201806010135)
National Key Research and Development Program of China (2022YFC2705005, 2022YFC2505800)
Guangdong Major Project of Basic and Applied Basic Research (HRB103)
Sun Yat-sen University Clinical Research 5010 Program (No. 201315, 2015021, 2017010, 2019023)
Innovative Research Team of High-level Local University in Shanghai (SSMU-ZLCX20180500)
Planned Science and Technology Project of Guangdong Province (2019B020230002)
Article History
Received: 6 December 2023
Accepted: 19 September 2024
First Online: 2 October 2024
Declarations
:
: This retrospective study was approved by the Clinical Research Committee of Sun Yat-sen University Cancer Centre.
: Patients were required to provide written informed consent before enrolling in the study. Informed consent was obtained from parents and/or guardian for research participants under 16 years of age.
: No applicable.
: The authors declare no competing interests.